A Case of Hypercalcemia due to Adult T-Cell Lymphoma

  • Faeze Moghimpour-Bijani Department of Internal Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Sahar Karimpour-Reyhan Assistant Professor, Department of Internal Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahsa Abbaszadeh Assistant Professor, Department of Internal Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Keywords: Leukemia-lymphoma, Adult T-cell, Human T-lymphotropic virus type 1, Hypercalcemi


Adult T-cell leukemia (ATL) is the only T-cell lymphoproliferative disease, known to be caused by a virus. While human T-lymphotropic virus type 1 (HTLV-1) is found to cause adult T-cell leukemia, other T-cell neoplastic diseases do not correlate with human T-lymphotropic virus type 1. Adult T-cell leukemia usually demonstrates an aggressive course and poor prognosis. Human T-lymphotropic virus type 1 is transmitted via breast feeding, sexual contact, shared needles, and infected blood products. Moreover, some geographic areas are depicted to be endemic for human T-lymphotropic virus type 1; northeast of Iran is known to be one. Here in, a case of adult T-cell leukemia is discussed who presented by hypercalcemia and paraparesia. Hepatosplenomegaly was detected in physical examination and abdominal sonography revealed multiple paraaortic lymphadenopathy. Whole body bone scan demonstrated multiple hot points in skeleton. Chest computed tomography (CT) scan revealed leukemic infiltrations of both lungs. The leukocyte count of peripheral blood was 34000-50000 per mm3, and excessive amounts of mature lymphocytes were observed in peripheral smear. Flow cytometry of bone marrow aspiration reported adult T-cell leukemia. The titer of human T-lymphotropic virus type 1 antibody was elevated in enzyme-linked immunosorbent assay (ELISA) method. Despite the patient was originated from a non-endemic origin, all members of his family including his spouse and children found to be positive for human T-lymphotropic virus type 1. This manuscript describes the clinical course and diagnosis of a patient with adult T-cell leukemia, and clinical suspicions during the course of the disease.


Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 2014; 164(4): 536-45.

Phillips AA, Shapira I, Willim RD, Sanmugarajah J, Solomon WB, Horwitz SM, et al. A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1 associated adult T-cell leukemia/lymphoma: A multicenter clinicopathologic experience and new prognostic score. Cancer 2010; 116(14): 3438-46.

Salehi M, Shokouhi Mostafavi SK, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 infection in Neyshabur city, NorthEastern Iran, during 2010 2014. Iran Biomed J 2017; 21(1): 57-60.

Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S. Prevention of mother-tochild transmission of human T-lymphotropic virus type-I. Pediatrics 1990; 86(1): 11-7.

Wignall FS, Hyams KC, Phillips IA, Escamilla J, Tejada A, Li O, et al. Sexual transmission of human T-lymphotropic virus type I in Peruvian prostitutes. J Med Virol 1992; 38(1): 44-8.

Poljak M, Bednarik J, Rednak K, Seme K, Kristancic L, Celan-Lucu B. Seroprevalence of human T cell leukaemia/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereological outpatient services and intravenous drug users from Slovenia. Folia Biol (Praha) 1998; 44(1): 23-5.

Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 2003; 22(33): 5131-40.

Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood 2015; 126(24): 2570-7.

Ravandi F, O'Brien S. Chronic lymphoid leukemias other than chronic lymphocytic leukemia: Diagnosis and treatment. Mayo Clin Proc 2005; 80(12): 1660-74.

Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010; 115(22): 4337-43.

Bunn PA Jr, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ, et al. Clinical course of retrovirus-associated adult T-cell

lymphoma in the United States. N Engl J Med 1983; 309(5): 257-64.

Foss FM, Aquino SL, Ferry JA. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10- 2003. A 72-year-old man with rapidly progressive leukemia, rash, and multiorgan failure. N Engl J Med 2003; 348(13): 1267-75.

Yamada Y, Kamihira S, Murata K, Yamamura M, Maeda T, Tsukasaki K, et al. Frequent hepatic involvement in adult T cell leukemia: Comparison with non-Hodgkin's lymphoma. Leuk Lymphoma 1997; 26(3-4): 327-35.

Alvarez C, Gotuzzo E, Vandamme AM, Verdonck K. Family aggregation of human t-lymphotropic virus 1-associated diseases: A systematic review. Front Microbiol 2016; 7: 1674.

Jaffe ES, Blattner WA, Blayney DW, Bunn PA Jr, Cossman J, Robert-Guroff M, et al. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virusassociated lymphoid malignancies. Am J Surg Pathol 1984; 8(4): 263-75.

Kikuchi M, Mitsui T, Takeshita M, Okamura H, Naitoh H, Eimoto T. Virus associated adult T-cell leukemia (ATL) in Japan: Clinical, histological and immunological studies. Hematol Oncol 1986; 4(1): 67 81.

Chadburn A, Athan E, Wieczorek R, Knowles DM. Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction. Blood 1991; 77(11): 2419-30.

Mahieux R. Virological aspects of HTLV-1

How to Cite
Moghimpour-Bijani F, Karimpour-Reyhan S, Abbaszadeh M. A Case of Hypercalcemia due to Adult T-Cell Lymphoma. CRCP. 2(4):120-125.
Case Report(s)